Ophthalmology

Cat-scratch disease
pp. 1-1(1)
Author: Lee A.G.

Cat-scratch disease: Author's reply
pp. 1-1(1)
Author: Ormerod L.D.

Management of B. henselae neuroretinitis in cat-scratch disease
pp. 1-2(2)
Author: Rosen B.

Management of B. henselae neuroretinitis in cat-scratch disease: Authors' reply
pp. 2-2(1)
Authors: Reed J.B.; Scales D.K.; Dolan M.J.

Retinal breaks
pp. 2-3(2)
Author: Wilkinson C.P.

Retinal breaks: Authors' reply
pp. 3-3(1)
Authors: Folk J.C.; Boldt H.C.

Cyclosporine and neovascularization
pp. 3-3(1)
Authors: Epstein R.J.; Hendricks R.L.; Lipman R.M.

Cyclosporine and neovascularization: Authors' reply
pp. 3-4(2)
Authors: Jaffe G.J.; Yang D.C.S.; Wang X.-c.; Cousins S.W.; Gallemore R.P.; Ashton P.

Pupil dilation using phenylephrine alone or in combination with tropicamide
pp. 4-4(1)
Author: Fraunfelder F.T.

Pupil dilation using phenylephrine alone or in combination with tropicamide: Author's reply
pp. 4-4(1)
Author: Eyeson-Annan M.L.

LASIK in different degrees of myopia
pp. 4-5(2)
Author: Salchow D.J.

LASIK in different degrees of myopia: Author's reply
pp. 5-5(1)
Author: Maldonado-Bas A.

Estimation of cataract blindness in India
pp. 5-5(1)
Author: Dandona L.

Estimation of cataract blindness in India: Author's reply
pp. 5-6(2)
Author: Robin A.L.

Ocular dominance in baseball players
pp. 6-7(2)
Author: Romano P.E.

Ocular dominance in baseball players: Authors' reply
pp. 7-8(2)
Authors: Laby D.M.; Kirschen D.G.; Rosenbaum A.L.; Mellman M.F.

Color coding medications
pp. 8-8(1)
Author: Bowers J.

Color coding medications: Reply
pp. 8-9(2)
Author: Gerenraich K.B.

Acknowledging the importance of study design in the organization and quality of manuscripts
pp. 11-12(2)
Author: Minckler D.

Complications of laser in situ keratomileusis for the correction of myopia
pp. 13-20(8)
Authors: Stulting R.D.; Carr J.D.; Thompson K.P.; Waring G.O.; Wiley W.M.; Walker J.G.

Retreatment after laser in situ keratomileusis
pp. 21-28(8)
Authors: Perez-Santonja J.J.; Ayala M.J.; Sakla H.F.; Ruiz-Moreno J.M.; Alio J.L.

Discussion by Mark E. Whitten, MD
pp. 28-28(1)
Author: Whitten M.E.

Epithelial removal with the excimer laser (laser-scrape) in photorefractive keratectomy retreatment
pp. 29-34(6)
Authors: Kapadia M.S.; Meisler D.M.; Wilson S.E.

Diabetes, hypertension, and central obesity as cataract risk factors in a black population - The Barbados Eye Study
pp. 35-41(7)
Authors: Leske M.C.; Wu S.-Y.; Hennis A.; Connell A.M.S.; Hyman L.; Schachat A.; The Barbados Eye Study Group

Intraoperative clinical practice and risk of early complications after cataract extraction in the United States, Canada, Denmark, and Spain
pp. 42-48(7)
Authors: Norregaard J.C.; Bernth-Petersen P.; Bellan L.; Alonso J.; Black C.; Dunn E.; Folmer Andersen T.; Espallargues M.; Anderson G.F.

The effect of polymethylmethacrylate, silicone, and polyacrylic intraocular lenses on posterior capsular opacification 3 years after cataract surgery
pp. 49-55(7)
Authors: Hollick E.J.; Spalton D.J.; Ursell P.G.; Pande M.V.; Barman S.A.; Boyce J.F.; Tilling K.

Discussion by Robert C. Drews, MD
pp. 54-55(2)
Author: Drews R.C.

Piggybacking intraocular implants to correct pseudophakic refractive error
pp. 56-59(4)
Authors: Gayton J.L.; Sanders V.; Van Der Karr M.; Raanan M.G.

Discussion by Jack T. Holladay, MD, MSEE, FACS
pp. 59-59(1)
Author: Holladay J.T.

A comparison of patient comfort during cataract surgery with topical anesthesia versus topical anesthesia and intracameral lidocaine
pp. 60-66(7)
Authors: Crandall A.S.; Zabriskie N.A.; Patel B.C.K.; Burns T.A.; Mamalis N.; Malmquist-Carter L.A.; Yee R.

Conjunctival rotation autograft for pterygium - An alternative to conjunctival autografting
pp. 67-71(5)
Authors: Jap A.; Chan C.; Lim L.; Tan D.T.H.

Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid
pp. 72-79(8)
Authors: Donnenfeld E.D.; Perry H.D.; Wallerstein A.; Caronia R.M.; Kanellopoulos A.J.; Sforza P.D.; D'Aversa G.

Discussion by Michael B. Raizman, MD
pp. 79-79(1)
Author: Raizman M.B.

In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin - Emerging resistance
pp. 80-85(6)
Authors: Kunimoto D.Y.; Sharma S.; Garg P.; Rao G.N.

Periocular atypical mycobacterial infections
pp. 86-90(5)
Authors: Chang W.J.; Tse D.T.; Rosa R.H.; Miller D.

Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia
pp. 91-97(7)
Authors: Vann R.R.; Karp C.L.

Primitive neuroectodermal tumor of the orbit in an adult - A case report and literature review
pp. 98-102(5)
Authors: Kiratli H.; Bilgic S.; Gedikoglu G.; Ruacan S.; Ozmert E.

Pleomorphic adenocarcinomas of the ciliary epithelium - Immunohistochemical and ultrastructural features of 12 cases
pp. 103-110(8)
Authors: Laver N.M.; Hidayat A.A.; Croxatto J.O.

Methotrexate treatment for sarcoid-associated panuveitis
pp. 111-118(8)
Authors: Dev S.; McCallum R.M.; Jaffe G.J.

Discussion by Robert A. Nozik, MD
pp. 118-118(1)
Author: Nozik R.A.

Molecular confirmation of carriers for Lowe syndrome
pp. 119-122(4)
Authors: Lin T.; Lewis R.A.; Nussbaum R.L.

Dominant optic atrophy - Refining the clinical diagnostic criteria in light of genetic linkage studies
pp. 123-128(6)
Authors: Johnston R.L.; Seller M.J.; Behnam J.T.; Burdon M.A.; Spalton D.J.

Identification of BK virus in a patient with acquired immune deficiency syndrome and bilateral atypical retinitis
pp. 129-132(4)
Authors: Hedquist B.G.; Bratt G.; Hammarin A.-L.; Grandien M.; Nennesmo I.; Sundelin B.; Seregard S.

Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome
pp. 133-141(9)
Authors: Tufail A.; Moe A.A.; Miller M.J.; Wagar E.A.; Bruckner D.A.; Holland G.N.

Methicillin-resistant Staphylococcus aureus infections after scleral buckling procedures for retinal detachments associated with atopic dermatitis
pp. 142-147(6)
Authors: Oshima Y.; Ohji M.; Inoue Y.; Harada J.; Motokura M.; Saito Y.; Emi K.; Tano Y.

Atovaquone for the treatment of toxoplasma retinochoroiditis in immunocompetent patients
pp. 148-153(6)
Authors: Pearson P.A.; Piracha A.R.; Sen H.A.; Jaffe G.J.

Retinal detachment in Olmsted County, Minnesota, 1976 through 1995
pp. 154-159(6)
Authors: Rowe J.A.; Erie J.C.; Baratz K.H.; Hodge D.O.; Gray D.T.; Butterfield L.; Robertson D.M.

Ocular complications of pediatric bone marrow transplantation
pp. 160-164(5)
Authors: Ng J.S.K.; Lam D.S.C.; Li C.K.; Chik K.W.; Cheng G.P.M.; Yuen P.M.P.; Tso M.O.M.

Decisions, decisions
pp. 165-168(4)
Author: Brubaker R.F.

Glaucoma after pars plana vitrectomy and silicone oil injection for complicated retinal detachments
pp. 169-177(9)
Authors: Honavar S.G.; Goyal M.; Majji A.B.; Sen P.K.; Naduvilath T.; Dandona L.

Discussion by Charles C. Barr, MD
pp. 177-177(1)
Author: Barr C.C.

Continuous visual field test supervision may not always be necessary
pp. 178-181(4)
Authors: Van Coevorden R.E.; Mills R.P.; Chen Y.Y.; Barnebey H.S.